First Time Loading...

Elevation Oncology Inc
NASDAQ:ELEV

Watchlist Manager
Elevation Oncology Inc Logo
Elevation Oncology Inc
NASDAQ:ELEV
Watchlist
Price: 3.55 USD -7.79%
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

ELEV Price Targets Summary
Elevation Oncology Inc

Wall Street analysts forecast ELEV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELEV is 7.91 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

ELEV Lowest Forecast
Wall Street Target
6.06 USD
71% Upside
ELEV Average Forecast
Wall Street Target
7.91 USD
123% Upside
ELEV Highest Forecast
Wall Street Target
10.5 USD
196% Upside
Lowest
Price Target
6.06 USD
71% Upside
Average
Price Target
7.91 USD
123% Upside
Highest
Price Target
10.5 USD
196% Upside
Elevation Oncology Inc Competitors:
Price Targets
ENLV
Enlivex Therapeutics Ltd
328% Upside
CYTK
Cytokinetics Inc
58% Upside
M
MLYS
Mineralys Therapeutics Inc
182% Upside
PYC
PYC Therapeutics Ltd
258% Upside
ENLV
Enlivex Therapeutics Ltd
328% Upside
CYTK
Cytokinetics Inc
58% Upside
M
MLYS
Mineralys Therapeutics Inc
182% Upside
PYC
PYC Therapeutics Ltd
258% Upside
N
4893
Noile-Immune Biotech Inc
184% Upside
TSVT
2Seventy Bio Inc
146% Upside
688363
Bloomage Biotechnology Corp Ltd
57% Upside
H
042520
Hans Biomed Corp
176% Upside

Revenue
Forecast

Revenue Estimate
Elevation Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Elevation Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Elevation Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
What are analyst estimates?

See Also

Summary
ELEV intrinsic value, competitors valuation, and company profile.
DCF Valuation
ELEV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ELEV stock valuation using valuation multiples.
Wall Street Estimates
ELEV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ELEV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ELEV's stock price target?
Price Target
7.91 USD

According to Wall Street analysts, the average 1-year price target for ELEV is 7.91 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

ALPHA SPREAD
Join more than 133,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.